Le Lézard
Classified in: Science and technology
Subject: LAW

Kansas Court of Appeals Rules in Favor of Aeroflex Wichita in Case Against Tel-Instrument Electronics Corp.


CHANDLER, Ariz., Aug. 8, 2023 /PRNewswire/ -- Viavi Solutions Inc. (VIAVI) (NASDAQ: VIAV) today announced that the Court of Appeals of the State of Kansas has affirmed a lower court decision in a case filed by Aeroflex Wichita, now a VIAVI company, against Tel-Instrument Electronics Corp. ("TIC") and two of its employees with total damages owed to VIAVI now exceeding US$7 million. The lower court case, filed by Aeroflex prior to the acquisition by VIAVI and affirmed by the Kansas Court of Appeals, awarded damages caused by tortious interference and improper use and disclosure of Aeroflex's confidential and proprietary business information used to win a competitive US Army contract to upgrade and supply the Army with avionics test sets.

In TIC's press release on July 27, 2023, TIC's President and CEO Jeff O'Hara stated that the appellate court's opinion was a "final decision" which entailed TIC's paying the full judgment and accrued interest amount. TIC also filed an 8-K with the SEC on that same day in which it referred to the appellate decision and "the Company's obligation to pay damages in full." VIAVI takes these statements to mean that TIC will not file a petition for review to the Kansas Supreme Court and that TIC will pay its portion of the judgment, costs, and interest. VIAVI is pursuing full payment of all amounts owed from TIC as a result of the Court of Appeals' judgment.

Aeroflex, now part of the VIAVI AvComm Business Unit, has delivered a broad portfolio of avionics test solutions, including reliable R&D, flight line, factory and return-to-service test solutions to the avionics market for more than 50 years. The company has served aircraft operators, avionics system manufacturers, and maintenance/depot, repair and overhaul service providers in the military, commercial and general aviation sectors.

"We are pleased that the Court found in our favor, and in their words, 'Justice was done,'" said Doug Russell, Senior Vice President, AvComm, VIAVI. "VIAVI and Aeroflex are proud of our history of innovation and support for our armed services. The integrity of the technology development process provides confidence to us and to our customers in the systems underlying our nation's defenses."

About VIAVI
VIAVI (NASDAQ: VIAV) is a global provider of network test, monitoring and assurance solutions for communications service providers, hyperscalers, equipment manufacturers, enterprises, government and avionics. VIAVI is also a leader in light management technologies for 3D sensing, anti-counterfeiting, consumer electronics, industrial, automotive, government and aerospace applications. Together with our customers and partners we are United in Possibility, finding innovative ways to solve real-world problems. Learn more about VIAVI at www.viavisolutions.com. Follow us on VIAVI Perspectives, LinkedIn, Twitter, YouTube and Facebook.

Media Inquiries:

North America

Sonus PR

Martin Smith

[email protected]

Europe, Middle East & Africa

Sonus PR

Chevaan Seresinhe

[email protected]

Asia Pacific

Voila Communications

Manish Sharma

[email protected]




China

Archetype

Geff Pan

[email protected]



 

SOURCE VIAVI Solutions


These press releases may also interest you

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

18 mai 2024
After tens of thousands of NYC children were turned away from "Summer Rising," New York City's popular, free summer enrichment program, Brains & Motion launched a campaign offering camps at NYU for a small fraction of the up-to-$1400 per week price...



News published on and distributed by: